MDK1654: A Branched Synthetic Peptide that Activates Both the IL-7 Receptor and the bgcForm of the IL-2/15 Receptor

Written By Guest User
Guest User
Previous

A Phase 1 Single Ascending Dose Study Evaluating the Safety, Tolerability, and Pharmacodynamic Effects of MDK-703, an IL-7 Mimetic With Extended Half-life
Next

PEGS Boston Summit 2022 - Discovery and Versatile Use of Peptide-Based Agonists of Hetero-Dimeric γc Cytokine Receptors